Christopher V Hajinian Attorney

Aim Immunotech is a biopharmaceutical company based in Ocala, Florida, focused on developing therapeutic solutions for a range of debilitating and life-threatening conditions. Their lead program, Ampligen, is an immuno modulator showing broad-spectrum activity in in vitro and animal testing, currently being evaluated in clinical studies for oncology, immune disorders, and viral diseases.

The company aims to improve lives by providing potential solutions across various disease areas, with recent highlights including the announcement of positive results in phase 1b/2 studies for late-stage pancreatic cancer. Led by CEO Thomas Equels, Aim Immunotech is dedicated to advancing immunology for a better future through innovative research and development efforts.

Generated from the website